ANAPTYSBIO, INC — Director's Dealing 2021

Nov 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2021-11-26

Reporting Person: Faga Daniel (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-26	Stock Option (Right to Buy)	$31.12	A	11000	Acquired	2031-11-25	Common Stock (11000)	Direct
2021-11-26	Stock Option (Right to Buy)	$31.12	A	2321	Acquired	2031-11-25	Common Stock (2321)	Direct

Footnotes

F1: 1/36th of the total shares subject to the option shall vest on December 26, 2021 and 1/36th of the total shares subject to the option shall vest on each monthly anniversary thereafter, subject to the reporting person's continuous status as a director through each such date.

F2: The option shall vest and become exercisable in full on February 10, 2022, subject to the reporting person's continuous status as a director through February 10, 2022.